NASDAQ:ROIV | Insider Transactions — Page 4 | Roivant Sciences Ltd.

ROIV Insider Transactions — Page 4

361 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 301–361; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
Venker EricPresident & COO2022-12-30Sale23,761.0$8.0
Venker EricPresident & COO2022-12-09Sale133,376.0$7.03
Venker EricPresident & COO2022-12-08Sale11,729.0$7.0
SoftBank Vision Fund L.P.TenPercentOwner2022-11-10Sale4,343,919.0$4.75
SVF Holdings (UK) LLPTenPercentOwner2022-11-10Sale4,343,919.0$4.75
SVF Investments (UK) LtdTenPercentOwner2022-11-10Sale4,343,919.0$4.75
SB INVESTMENT ADVISERS (UK) LTDTenPercentOwner2022-11-10Sale4,343,919.0$4.75
Dexxon Holdings Ltd.TenPercentOwner2022-11-10Purchase4,000,000.0$5.0
Oren DanTenPercentOwner2022-11-10Purchase4,000,000.0$5.0
Dexcel Pharma Technologies Ltd.TenPercentOwner2022-11-10Purchase4,000,000.0$5.0
QVT Financial LPDirector,TenPercentOwnerOther2022-11-10Sale146,079.0$4.75
QVT Financial LPDirector,TenPercentOwnerOther2022-11-10Sale2,311,643.0$4.75
QVT Financial LPDirector,TenPercentOwnerOther2022-11-10Sale372,427.0$4.75
QVT Financial LPDirector,TenPercentOwnerOther2022-11-10Sale1,733,577.0$4.75
QVT Financial LPDirector,TenPercentOwnerOther2022-11-10Sale1,092,355.0$4.75
Gold Daniel AllenDirector2022-11-10Sale146,079.0$4.75
Gold Daniel AllenDirector2022-11-10Sale2,311,643.0$4.75
Gold Daniel AllenDirector2022-11-10Sale372,427.0$4.75
Gold Daniel AllenDirector2022-11-10Sale1,733,577.0$4.75
Gold Daniel AllenDirector2022-11-10Sale1,092,355.0$4.75
MANCHESTER KEITH SDirector2022-11-10Sale146,079.0$4.75
MANCHESTER KEITH SDirector2022-11-10Sale2,311,643.0$4.75
MANCHESTER KEITH SDirector2022-11-10Sale372,427.0$4.75
MANCHESTER KEITH SDirector2022-11-10Sale1,092,355.0$4.75
Gline MatthewCEO2022-10-25Sale19,276.0$4.4
Kumar RakhiChief Accounting Officer2022-10-25Sale1,588.0$4.4
Venker EricPresident & COO2022-10-25Sale15,922.0$4.4
Kumar RakhiChief Accounting Officer2022-09-23Sale1,741.0$3.07
Venker EricPresident & COO2022-09-23Sale17,392.0$3.07
Gline MatthewCEO2022-09-23Sale21,053.0$3.07
Kumar RakhiChief Accounting Officer2022-08-24Sale1,652.0$3.71
Venker EricPresident & COO2022-08-24Sale16,530.0$3.71
Gline MatthewCEO2022-08-24Sale20,009.0$3.71
Gline MatthewCEO2022-07-25Sale20,455.0$4.33
Kumar RakhiChief Accounting Officer2022-07-25Sale1,686.0$4.33
Venker EricPresident & COO2022-07-25Sale16,896.0$4.33
Kumar RakhiChief Accounting Officer2022-06-23Sale1,635.0$4.34
Gline MatthewCEO2022-06-23Sale19,855.0$4.34
Venker EricPresident & COO2022-06-23Sale16,402.0$4.34
Gline MatthewCEO2022-05-20Sale139,791.0$3.7
Venker EricPresident & COO2022-05-20Sale136,421.0$3.7
Kumar RakhiChief Accounting Officer2022-05-20Sale12,127.0$3.7
Kumar RakhiChief Accounting Officer2022-04-25Sale703.0$3.84
Venker EricPresident & COO2022-04-25Sale5,107.0$3.84
Gline MatthewCEO2022-04-25Sale8,509.0$3.84
Dexxon Holdings Ltd.TenPercentOwner2022-04-25Purchase8,600.0$3.91
Oren DanTenPercentOwner2022-04-25Purchase8,600.0$3.91
Dexcel Pharma Technologies Ltd.TenPercentOwner2022-04-25Purchase8,600.0$3.91
Dexxon Holdings Ltd.TenPercentOwner2022-04-22Purchase31,685.0$3.83
Oren DanTenPercentOwner2022-04-22Purchase31,685.0$3.83
Dexcel Pharma Technologies Ltd.TenPercentOwner2022-04-22Purchase31,685.0$3.83
Venker EricPresident & COO2022-03-30Sale19,336.0$4.84
Kumar RakhiChief Accounting Officer2022-03-30Sale2,486.0$4.84
Gline MatthewCEO2022-03-30Sale33,686.0$4.84
Venker EricPresident & COO2022-03-25Sale80,045.0$5.06
Gline MatthewCEO2022-03-25Sale35,386.0$5.06
Kumar RakhiChief Accounting Officer2022-03-25Sale7,281.0$5.06
Kumar RakhiChief Accounting Officer2022-03-18Sale2,153.0$5.13
Gline MatthewCEO2022-03-18Sale82,006.0$5.13
Kumar RakhiChief Accounting Officer2022-03-07Sale3,091.0$5.52
Gline MatthewCEO2022-03-07Sale92,324.0$5.52